Ninth Annual Immunogenicity Bioassay Summit
Date: October 23 - 26, 2017
Venue: The Westin Alexandria, Washington, DC USA

Join us at the #1 Immunogenicity & Bioassay Event in the U.S. for CHI's Ninth Annual Immunogenicity and Bioassay Summit. The summit will host 250+ industry, academia and regulatory authorities who will share new ways of overcoming immunogenicity and bioassay challenges at 3 co-located conferences, 5 short courses, and 2 training seminars.  Plus, a full day symposium on Bioassays for Immuno-Oncology. We extend our gratitude to all past speakers, alumni, sponsors and exhibitors for making this event happen. All speaker submitters will be notified of their status.

Keynote & Featured Speakers

Viswanath_DevanarayanViswanath Devanarayan, Ph.D.

Adjunct Professor

University of Illinois at Chicago

Susan_KirshnerSusan Kirshner, Ph.D.

Associate Chief, Immunology Lab, Therapeutic Proteins, Biotechnology

FDA/CDER

Thomas_LittleThomas Little, Ph.D.

President, Bioassay Sciences

Thomas A. Little Consulting

Sofie_PattijnSofie Pattijn

Chief Technology Officer

ImmunXperts

Joao_Pedras-VasconcelosJoao Pedras-Vasconcelos, Ph.D.

Biotech Quality and Immunogenicity Reviewer, Biotechnology Products

CDER-FDA

Amy_RosenbergAmy S. Rosenberg, M.D.

Division Director, Office of Biotechnology Products

FDA/CDER

Perceval_SondagPerceval Sondag

Senior Statistician, Non-Clinical Statistics

Arlenda

2016 Event Stats:

  • 250+ Delegates from 145 Companies
  • 60 Speakers
  • 25 Posters Presented
  • 15 Countries Represented
  • 14 Exhibiting Companies

View the 2016 Attendee List

Here's what one of our delegate's on-site said:

"CHI's Optimizing Bioassay for Biologics is one of the best bioassay venues in the biotech and biopharma industry. The conference provides very deep and broad scientific presentations, roundtable discussions, and excellent network opportunities for scientists, managers/directors, CROs, vendors and consultants."
- Senior Group Leader, Bioassay Development, Hospira, a Pfizer Company

Testimonials

"Program and participants first class."
- Associate Director, Novo Nordisk

"Breakout interaction with FDA experts was very valuable."
- Associate Director, Alexion Pharmaceuticals Inc.

"Interesting new data and very relevant to the field."
- Senior Scientist, Process Development, Amgen, Inc.

"Provided good overview of current problems and progress in the field."
- Scientist, Bioanalytical Sciences, Immunogen

"Congratulations on a very well put together conference."
- Assistant Vice President, Pfizer

View more testimonials

Choose your language
Japanese
Traditional Chinese
Simplified Chinese
Korean

Download Brochure
Download Brochure(PDF)

Conference at a glance

Celebrating 25 years